Contraception Navigator Program
Launched by INDIANA UNIVERSITY · Jan 18, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Contraception Navigator Program is a study aimed at helping young people in Central Indiana who want to access birth control. The researchers believe that by providing support and resources for adolescents, they can help them feel more confident in making choices about contraception and increase the use of hormonal birth control methods. This program is particularly focused on female adolescents aged 15 to 19 who speak English and live in Indiana.
If you or someone you know fits this age range and meets the eligibility criteria, you might be able to participate in the trial. Participants can expect guidance and assistance in accessing birth control options, which can lead to more informed decisions about their reproductive health. It's important to note that this study is currently recruiting participants, so there’s an opportunity to get involved and benefit from the resources being offered.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adolescents between the ages of 15-19 yrs
- • English speaking
- • Lives in Indiana
- Exclusion Criteria:
- • Adolescents younger than 15 or older than 19 yrs
- • Non-English speaking
- • Lives outside of Indiana
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials